In the Original Investigation titled “Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy,”1 published online July 7, 2020, there was an error in Figure 2. In the scale in panel A, red should indicate 1.5 and blue should indicate 1.0. This article was corrected online.
Reference
- 1.Brendel M, Barthel H, van Eimeren T, et al. Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy. JAMA Neurol. Published online July 7, 2020. doi: 10.1001/jamaneurol.2020.2526 [DOI] [PMC free article] [PubMed] [Google Scholar]
